Translate Bio Inc. (NASDAQ:TBIO) Recent Earnings Shows Major Promise

Translate Bio Inc. (NASDAQ:TBIO) Recent Earnings Shows Major Promise

SHARE

The Translate Bio Inc. (TBIO) shares are trading at higher $26.66 and the avg recommendation for the stock is Strong Buy. The current analyst price target stands at $20.33.

To add more color to this target, the company’s high over the last year is $27.24 and the low is $6.80. Over the last 52 weeks, TBIO is down -2.13% while the S&P 500 is down -2.55%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, TBIO reported a profit of $19.45 million. Translate Bio Inc. also saw revenues increase to $4.65 million. In addition, TBIO has free cash flow of -$33.77 million as of 03-2020 The company’s EBITDA came in at -$13.44 million which compares well with its peers.

TBIO Return on Equity (ROE) is -63.60%, and its Return on Assets is -29.20%. All told, it is clear that, TBIO needs to be on your watchlist.

Find out when TBIO reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. TBIO has a short ratio of 1.90 and outstanding shares of 60.01M.

Company Outlook

TBIO has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 3.37 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.74. Translate Bio Inc. TBIO also noted assets of $305.24 million at the end of the last quarter. Investors should also keep an eye on sector updates as TBIO has historically followed its peers on positive news.

All told, Translate Bio Inc. TBIO has strung together solid data and demonstrated underlying fundamentals. At its current valuation, TBIO represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Translate Bio Inc. TBIO is now commanding a market cap of 1.77B and a float of 51.64M. TBIO is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of TBIO stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in TBIO, either long or short, and we have not been compensated for this article.